Donation boosts CAR T-cell therapy potential for the future

Icon Writers / 24 Jun, 2024

A generous donation has been received from an anonymous benefactor to advance the work of Icon Cancer Foundation. This substantial contribution will allow Icon to explore future research in cellular therapy, including CAR T-cell therapy in myeloma.

What is CAR T-cell therapy? It’s a cutting-edge treatment that is showing promise for blood cancers and potentially other types of cancers.

Current availability: In Australia, CAR T-cell therapy is limited to a small number of public hospitals due to the high cost.

We extend our heartfelt gratitude to the donor for their incredible support and investment in our mission, bringing hope to patients by helping advance cancer treatments through research.

Read more about CAR T-cell therapy

View all News & Updates


Quick links